NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 203 filers reported holding NATERA INC in Q4 2019. The put-call ratio across all filers is 0.16 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,979,797 | +12.8% | 248,131 | +24.0% | 2.08% | +60.9% |
| Q2 2023 | $9,736,574 | -25.8% | 200,094 | -15.4% | 1.29% | -2.9% |
| Q1 2023 | $13,126,594 | +98.0% | 236,430 | +43.3% | 1.33% | +288.6% |
| Q4 2022 | $6,628,050 | +210.9% | 165,000 | +174.3% | 0.34% | +175.8% |
| Q2 2022 | $2,132,000 | -90.3% | 60,159 | -74.4% | 0.12% | -84.4% |
| Q4 2021 | $21,965,000 | -18.1% | 235,199 | -2.3% | 0.80% | -2.6% |
| Q3 2021 | $26,823,000 | +9.0% | 240,693 | +11.0% | 0.82% | +6.5% |
| Q2 2021 | $24,615,000 | -2.1% | 216,816 | -12.4% | 0.77% | +6.8% |
| Q1 2021 | $25,146,000 | +24.8% | 247,644 | +22.3% | 0.72% | -2.2% |
| Q4 2020 | $20,153,000 | +46.8% | 202,500 | +6.6% | 0.73% | +3.7% |
| Q3 2020 | $13,726,000 | +212.7% | 190,000 | +45.8% | 0.71% | +83.2% |
| Q4 2019 | $4,390,000 | +346.1% | 130,300 | +334.3% | 0.39% | +129.8% |
| Q3 2019 | $984,000 | -42.0% | 30,000 | -57.7% | 0.17% | -52.9% |
| Q3 2018 | $1,697,000 | – | 70,871 | – | 0.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
| Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
| Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
| Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
| Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
| BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
| Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
| Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
| Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
| SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |